1-methyl-1,2,3,4-tetrahydroisoquinoline has been researched along with Disease Models, Animal in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Antkiewicz-Michaluk, L; Białoń, M; Chocyk, A; Majcher-Maślanka, I; Michalski, K; Wąsik, A; Żarnowska, M | 1 |
| Antkiewicz-Michaluk, L; Michaluk, J; Możdżeń, E; Romańska, I; Wąsik, A | 2 |
| Antkiewicz-Michaluk, L; Michaluk, J; Romańska, I; Wąsik, A | 1 |
| Andres-Mach, M; Antkiewicz-Michaluk, L; Florek-Luszczki, M; Haratym-Maj, A; Luszczki, JJ; Raszewski, G; Zadrożniak, A | 1 |
| Andres-Mach, M; Haratym-Maj, A; Luszczki, JJ; Zagaja, M | 1 |
| Antkiewicz-Michaluk, L; Michaluk, J; Nalepa, I; Romańska, I; Wąsik, A; Zelek-Molik, A | 1 |
| Antkiewicz-Michaluk, L; Gołembiowska, K; Michaluk, J; Pietraszek, M; Romańska, I; Wasik, A | 1 |
| Antkiewicz-Michaluk, L; Czuczwar, SJ; Luszczki, JJ; Raszewski, G | 1 |
| Antkiewicz-Michaluk, L; Filip, M; Michaluk, J; Przegaliński, E; Romańska, I; Vetulani, J | 1 |
| Abe, K; Miyatake, T; Ren, J; Sano, T; Shinohara, T; Taguchi, K; Utsunomiya, I; Wasai, T | 1 |
| Abe, K; Ishiwata, K; Kawamura, K; Koyanagi, Y; Saitoh, T; Sano, T; Senda, M; Taguchi, K; Toda, J | 1 |
12 other study(ies) available for 1-methyl-1,2,3,4-tetrahydroisoquinoline and Disease Models, Animal
| Article | Year |
|---|---|
1MeTIQ and olanzapine, despite their neurochemical impact, did not ameliorate performance in fear conditioning and social interaction tests in an MK-801 rat model of schizophrenia.
Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Dizocilpine Maleate; Dopamine; Dopamine Antagonists; Fear; Male; Olanzapine; Rats; Rats, Sprague-Dawley; Schizophrenia; Social Interaction; Tetrahydroisoquinolines | 2021 |
Antidepressant-like effect of 1,2,3,4-tetrahydroisoquinoline and its methyl derivative in animal models of depression.
Topics: Animals; Antidepressive Agents; Brain; Chromatography, High Pressure Liquid; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Hindlimb Suspension; Imipramine; Male; Mice; Mice, Inbred C57BL; Swimming; Tetrahydroisoquinolines | 2017 |
Antidepressant-Like Effect of the Endogenous Neuroprotective Amine, 1MeTIQ in Clonidine-Induced Depression: Behavioral and Neurochemical Studies in Rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Biogenic Monoamines; Brain; Brain Chemistry; Clonidine; Depression; Disease Models, Animal; Freezing Reaction, Cataleptic; Homovanillic Acid; Locomotion; Male; Neuroprotective Agents; Psychomotor Performance; Rats; Rats, Wistar; Swimming; Sympatholytics; Tetrahydroisoquinolines | 2017 |
Effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline on the protective action of various antiepileptic drugs in the maximal electroshock-induced seizure model: a type II isobolographic analysis.
Topics: Animals; Anticonvulsants; Brain; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroshock; Male; Mice; Muscle Strength; Muscle, Skeletal; Psychomotor Performance; Seizures; Tetrahydroisoquinolines | 2013 |
Antidepressant-like effect of tetrahydroisoquinoline amines in the animal model of depressive disorder induced by repeated administration of a low dose of reserpine: behavioral and neurochemical studies in the rat.
Topics: Animals; Antidepressive Agents; Depressive Disorder; Disease Models, Animal; Dopamine; Hypothalamus; Male; Motor Activity; Neuropsychological Tests; Norepinephrine; Nucleus Accumbens; Rats, Wistar; Reserpine; Serotonin; Tetrahydroisoquinolines | 2014 |
Additive interactions between 1-methyl-1,2,3,4-tetrahydroisoquinoline and clobazam in the mouse maximal electroshock-induced tonic seizure model--an isobolographic analysis for parallel dose-response relationship curves.
Topics: Animals; Anticonvulsants; Benzodiazepines; Clobazam; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Electroshock; Male; Mice; Seizures; Tetrahydroisoquinolines | 2014 |
Neuroprotective Effect of the Endogenous Amine 1MeTIQ in an Animal Model of Parkinson's Disease.
Topics: Animals; Brain; Corpus Striatum; Disease Models, Animal; Dopamine; Hyperkinesis; Male; Neuroprotective Agents; Parkinson Disease; Parkinsonian Disorders; Rats; Rats, Wistar; Tetrahydroisoquinolines | 2016 |
1-Methyl-1,2,3,4-tetrahydroisoquinoline antagonizes a rise in brain dopamine metabolism, glutamate release in frontal cortex and locomotor hyperactivity produced by MK-801 but not the disruptions of prepulse inhibition, and impairment of working memory in
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Brain; Disease Models, Animal; Dizocilpine Maleate; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Glutamic Acid; Hyperkinesis; Inhibition, Psychological; Male; Maze Learning; Memory Disorders; Microdialysis; Motor Activity; Neurochemistry; Prefrontal Cortex; Rats; Rats, Wistar; Reflex, Startle; Tetrahydroisoquinolines | 2009 |
Interactions of 1-methyl-1,2,3,4-tetrahydroisoquinoline with lamotrigine, oxcarbazepine, pregabalin, and topiramate in the mouse maximal electroshock-induced seizure model: a type I isobolographic analysis.
Topics: Animals; Anticonvulsants; Avoidance Learning; Carbamazepine; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Electroshock; Fructose; gamma-Aminobutyric Acid; Lamotrigine; Male; Memory; Mice; Oxcarbazepine; Pregabalin; Seizures; Tetrahydroisoquinolines; Topiramate; Triazines | 2010 |
An endogenous neuroprotectant substance, 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ), prevents the behavioral and neurochemical effects of cocaine reinstatement in drug-dependent rats.
Topics: Animals; Behavior, Animal; Brain; Brain Chemistry; Cocaine; Cocaine-Related Disorders; Disease Models, Animal; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Limbic System; Male; Neural Pathways; Neuroprotective Agents; Norepinephrine; Rats; Reward; Secondary Prevention; Self Administration; Serotonin; Substance Withdrawal Syndrome; Tetrahydroisoquinolines; Ventral Tegmental Area | 2007 |
Stereoselective effect of (R)- and (S)-1-methyl-1,2,3,4-tetrahydroisoquinolines on a mouse model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Carbidopa; Cell Count; Disease Models, Animal; Dopamine; Dopamine Antagonists; Drug Interactions; Homovanillic Acid; Hydroxyindoleacetic Acid; Hypokinesia; Immunohistochemistry; Isoquinolines; Levodopa; Male; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Neurotoxins; Parkinsonian Disorders; Serotonin; Stereoisomerism; Substantia Nigra; Tetrahydroisoquinolines; Tyrosine 3-Monooxygenase | 2001 |
Evaluation of neurotoxicity of TIQ and MPTP and of parkinsonism-preventing effect of 1-MeTIQ by in vivo measurement of pre-synaptic dopamine transporters and post-synaptic dopamine D(2) receptors in the mouse striatum.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Binding, Competitive; Corpus Striatum; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Hypokinesia; Isoquinolines; Ligands; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Parkinsonian Disorders; Radioligand Assay; Receptors, Dopamine D2; Stereoisomerism; Substantia Nigra; Synapses; Tetrahydroisoquinolines; Tyrosine 3-Monooxygenase; Up-Regulation | 2001 |